MK
Madhumita Kumari
About Madhumita Kumari
Data last updated:
Madhumita Kumari is a Director at Langelie Biologicals Pharma Private Limited (since 2019). The company operates in Pharma. Langelie Biologicals Pharma Private Limited reported revenue of ₹44.7 Lakh (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Langelie Biologicals Pharma Private Limited U24230BR2009PTC014749 | Director | 01 Nov 2019 | 2009 | ₹44.7 Lakh (FY 2024) | Active |
Board colleagues of Madhumita Kumari
| Name | DIN | Company | Designation |
|---|---|---|---|
| Alpana | 03618892 | Langelie Biologicals Pharma Private Limited | Director |
| Manish Kumar | 02717038 | Langelie Biologicals Pharma Private Limited | Managing Director |
| Vivek Kumar Sinha | 02717032 | Langelie Biologicals Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Madhumita Kumari
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Madhumita Kumari
Madhumita Kumari currently holds 1 directorship: Langelie Biologicals Pharma Private Limited (Director, since 01 Nov 2019, revenue ₹44.7 Lakh (FY 2024)).
Madhumita Kumari was first appointed on 01 Nov 2019 as Director at Langelie Biologicals Pharma Private Limited.
The current boards of Madhumita Kumari's companies include Alpana (Langelie Biologicals Pharma Private Limited), Manish Kumar (Langelie Biologicals Pharma Private Limited), Vivek Kumar Sinha (Langelie Biologicals Pharma Private Limited).